oxazepam hemisuccinate

RN given refers to cpd without isomeric designation; structure in Negwer, 5th ed, #3843

Also Known As:

oxazepam hemisuccinate, (+)-isomer; oxazepam hemisuccinate, (+-)-isomer; oxazepam hemisuccinate, (-)-isomer; oxazepam hemisuccinate, (S)-isomer; oxazepam hemisuccinate, monosodium salt; oxazepam hemisuccinate, monosodium salt, (+)-isomer; oxazepam hemisuccinate, monosodium salt, (+-)-isomer; oxazepam hemisuccinate, monosodium salt, (-)-isomer; oxazepam hemisuccinate, monosodium salt, (R)-isomer; oxazepam hemisuccinate, monosodium salt, (S)-isomer; butanedioic acid, mono(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl) ester

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzazepines: 5
      - Benzodiazepines: 8452
        Benzodiazepinones
        Oxazepam: 195
        oxazepam hemisuccinate: 2

Related Diseases

1.	Muscle Spasticity (Spastic) 01/01/1972 - "[Double-blind evaluation of a combined oxazepam hemisuccinate-hexadiphane treatment versus hexadiphane in the therapy of visceral spastic syndromes]."
2.	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/01/1971 - "A double-blind study of an oxazepam hemisuccinate-hexadiphane combination in management of gastrointestinal disorders."

Related Therapies and Procedures

1.	Therapeutics